Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Offices

Funding

TOTAL $708k
FUNDING TOTAL $708k
Venture Round, 5/2011
High-Tech Gruenderfonds
€500k

Tags

MYR

MYR GmbH is a Burgwedel (Hannover), Germany-based biotech company that develops a drug for the treatment of chronic hepatitis B and D infections.

Recent Milestones

  • Check
    MYR — German-Russian Biomedical Companies Hepatera And MYR Receive Monetary Booster (4/12/12)
    Posted 4/13/12 at 1:44pm via invest-iq.net
  • Dollar
    MYR received $708k (€500k) in Venture Round funding. (5/12/11)
    Posted 5/12/11 at 8:15pm via finsmes.com

Videos

Screenshots

Sources

  1. MYR Receives €500K Equity Investment from High-Tech Gründerfonds (finsmes.com) [edit]
  2. German-Russian Biomedical Companies Hepatera And MYR Receive Monetary Booster (invest-iq.net) [edit]
Edit This Page
Last Edited 4/15/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy